Hosted on MSN
Artivion secures FDA approval for NEXUS aortic arch device, weighs Endospan acquisition
Artivion Inc. (NYSE:AORT) said the U.S. Food and Drug Administration has approved the premarket application for the NEXUS Aortic Arch System, a device developed by its partner Endospan Ltd. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results